1.A Case of Adrenocortical Carcinoma Secreting Cortisol, Androgen and Aldosterone.
Jae Ho CHOI ; Ye Ri SO ; Yu Chul HWANG ; In Kyung JEONG ; Kyu Jeung AHN ; Ho Yeon CHUNG ; Seung Ae YANG
Endocrinology and Metabolism 2011;26(3):239-242
Primary adrenocortical carcinoma is a rare tumor, and is characterized by a peri-tumor mass effect and hormone excess signs. Adrenocortical carcinoma most commonly secretes cortisol, but tumors that secrete other adrenal hormones (aldosterone, androgen) are rare. Herein, we report the case of a 70-year-old woman with cortisol, androgen, and aldosterone-secreting adrenal carcinoma. The patient complained of generalized weakness, moon face, and central obesity. On laboratory examination, hypokalemia and metabolic alkalosis was detected. On the hormone test, cortisol, DHEA-S, and aldosterone were all increased. Abdominal CT showed a large right adrenal mass. She underwent right adrenalectomy and the histology revealed the presence of an adrenocortical carcinoma. After adrenalectomy, the patient was treated with hydrocortisone and mitotane.
Adrenalectomy
;
Adrenocortical Carcinoma
;
Aged
;
Aldosterone
;
Alkalosis
;
Cushing Syndrome
;
Female
;
Humans
;
Hydrocortisone
;
Hypokalemia
;
Mitotane
;
Obesity, Abdominal
2.Estrogen Producing Adrenocortical Carcinoma.
Sueng Tae LEE ; Bum Jin PARK ; Dae Sung KIM ; Jung Su NAM ; Young Goo LEE ; Heung Won PARK ; Ki Kyung KIM ; Chong Woo YOO
Korean Journal of Urology 2003;44(10):1067-1069
An estrogen producing adrenocortical carcinoma is a rare, highly malignant tumor. Fewer than 100 cases of feminizing adrenocortical carcinomas in men have been reported. These tumors are usually large in size and show high levels of serum total estrogen and estradiol. Recently, two cases of estrogen producing adrenocortical carcinoma were experienced by our selves during in year. A unilateral adrenalectomy, with mass excision, was performed in both patients, with an ipsilateral nephrectomy performed in just one. Mitotane or cisplatin based adjuvant chemotherapy was also performed.
Adrenalectomy
;
Adrenocortical Carcinoma*
;
Chemotherapy, Adjuvant
;
Cisplatin
;
Drug Therapy
;
Estradiol
;
Estrogens*
;
Humans
;
Male
;
Mitotane
;
Nephrectomy
3.A Case of Adrenal Cortical Carcinoma with Invasion of Inferior Vena Cava.
Myung Ho YOON ; Seong Hyun GOO ; Yoon Sok CHUNG ; Hyeon Man KIM ; Hyun Soo KIM ; Hugh Chul KIM ; Hi Bung PARK ; Hyun Ee YIM
Korean Journal of Medicine 1997;52(5):678-684
The adrenal cortical carcinoma is a rare cancer with an estimated incidence of about 1 case per 1,700,000 population. Further development of the tumor thrombi invasion of the inferior vena cava is very rare. The adrenal cortical carcinoma has poor prognosis due to delayed onset of symptoms and signs with regional and metastatic diseases are about 70M at the time of diagnosis. The diagnosis is made by hormonal and imaging studies. Adrenal cortical carcinoma is slightly more frequent in female and hormonally non-functioning tumor is more frequent. Traditionally, surgery and mitotane chemotherapy are known as a valuable therapeutic modality. But recently usefullness of mitotane is questioned due to low response rate and complication such as gastrointestinal trouble and there is not established optimal dosage and duration of treatment. Recently, in metastatic adrenal cortical carcinoma, some literature with combined chemotherapy had tried and reported good response. But, in general, combined chemotherapy has known as ineffective. We experienced and report adrenal cortical carcinoma with inferior vena caval invasion which is diagnosed by computed tomography and magnetic resonance imaging, and we treated surgery and postoperative chemotherapy.
Adrenocortical Carcinoma*
;
Diagnosis
;
Drug Therapy
;
Female
;
Humans
;
Incidence
;
Magnetic Resonance Imaging
;
Mitotane
;
Prognosis
;
Vena Cava, Inferior*
4.A Case of an Adrenocortical Carcinoma with Pulmonary Embolism as the Initial Manifestation.
Hyo Jin LEE ; Ji Young KWAK ; Young Jip KIM ; Tae Ho KIM ; Jan Dee LEE ; Hyun Woo LEE ; Hae Jin KIM ; Dae Jung KIM ; Yoon Sok CHUNG ; Kwan Woo LEE ; Seung Jin HAN
Endocrinology and Metabolism 2012;27(1):93-97
The annual incidence of a first episode of deep vein thrombosis or pulmonary embolism (PE) in the general population is 120 per 100,000. Cancer is associated with an approximately 4- to 7-fold higher risk of thrombosis. Adrenocortical carcinoma (ACC) is a rare type of malignancy, accounting for 0.02% of all cancers reported annually. Approximately 40% of ACCs are nonsecretory. Most patients with nonsecreting tumors have clinical manifestations related to tumor growth (e.g., abdominal or flank pain). Often the adrenal mass is detected by chance via radiographic imaging. As a result, most ACC patients are diagnosed at an advanced stage and have a poor prognosis. Herein, we report a case of a 54-year-old woman who was admitted to our emergency department complaining of dyspnea. She was diagnosed with ACC accompanied by thrombi in the pulmonary artery and inferior vena cava. We performed a left adrenalectomy and administered adjuvant radiotherapy. The patient is currently receiving warfarin and adjuvant mitotane therapy. She was incidentally diagnosed with ACC, with PE as the initial manifestation.
Accounting
;
Adrenalectomy
;
Adrenocortical Carcinoma
;
Dyspnea
;
Emergencies
;
Female
;
Humans
;
Incidence
;
Middle Aged
;
Mitotane
;
Prognosis
;
Pulmonary Artery
;
Pulmonary Embolism
;
Radiotherapy, Adjuvant
;
Thrombosis
;
Vena Cava, Inferior
;
Venous Thrombosis
;
Warfarin
5.A case of adrenal gland dependent hyperadrenocorticism with mitotane therapy in a Yorkshire terrier dog.
Young Mi LEE ; Byeong Teck KANG ; Dong in JUNG ; Chul PARK ; Ha Jung KIM ; Ju Won KIM ; Chae Young LIM ; Eun Hee PARK ; Hee Myung PARK
Journal of Veterinary Science 2005;6(4):363-366
Hyperadrenocorticism, a disorder characterized by excessive production of cortisol by the adrenal cortex, is wellrecognized in dogs. A 10-year-old, intact male, Yorkshire terrier dog was evaluated because of corneal ulceration and generalized alopecia. Diagnosis was made based on history taking, clinical signs, physical examination, and results of routine laboratory testing (complete blood count, serum biochemical analysis, and urinalysis). In addition, adrenocorticotropic hormone (ACTH) stimulation test and abdominal ultrasonography were also used to diagnose this case. The patient was diagnosed as adrenal gland neoplasia and medical therapy using the adrenocorticolytic agent, mitotane, was initiated. An ACTH stimulation test was performed after initial therapy. After successful induction was obtained, maintenance therapy with mitotane still continued.
Adrenal Gland Neoplasms/complications/diagnosis/drug therapy/*veterinary
;
Adrenocortical Hyperfunction/diagnosis/drug therapy/etiology/*veterinary
;
Adrenocorticotropic Hormone/blood
;
Animals
;
Antineoplastic Agents, Hormonal/*therapeutic use
;
Dog Diseases/*drug therapy
;
Dogs
;
Male
;
Mitotane/*therapeutic use
;
Radiography, Abdominal/veterinary
;
Tomography, X-Ray/veterinary